{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:03:43Z","timestamp":1777647823121,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2047-783x-19-35","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T01:04:32Z","timestamp":1403658272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The prevalence of BRCA1\/2 mutations of triple-negative breast cancer patients in Xinjiang multiple ethnic region of China"],"prefix":"10.1186","volume":"19","author":[{"given":"Yong Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang Hua","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"146_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD: BRCA1 and BRCA2: 1994 and beyond. Nat Rev Canc 2004, 4: 665\u2013676. 10.1038\/nrc1431","journal-title":"Nat Rev Canc"},{"key":"146_CR2","first-page":"1049","volume":"33","author":"ML Zhang","year":"2012","unstructured":"Zhang ML, Huang ZZ, Zheng Y: Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008 (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi 2012, 33: 1049\u20131051.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"146_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-011-1596-x","volume":"132","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y: Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Breast Canc ResTreat 2012, 132: 421\u2013428. 10.1007\/s10549-011-1596-x","journal-title":"Breast Canc ResTreat"},{"key":"146_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10549-009-0598-4","volume":"120","author":"AY Cao","year":"2010","unstructured":"Cao AY, Hu Z, Shao ZM: Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Canc Res Treat 2010, 120: 271\u2013272. 10.1007\/s10549-009-0598-4","journal-title":"Breast Canc Res Treat"},{"key":"146_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmg.2008.062232","volume":"46","author":"DG Evans","year":"2009","unstructured":"Evans DG, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HF, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Kr\u00e4mling C, Campbell J, Hopwood P, Lalloo F, Howell A: Risk reducing mastectomy:outcomes in 10 European centres. J Med Genet 2009, 46: 254\u2013258. 10.1136\/jmg.2008.062232","journal-title":"J Med Genet"},{"key":"146_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4048\/jbc.2013.16.1.50","volume":"16","author":"O Jianghua","year":"2013","unstructured":"Jianghua O, Tao W, Sijmons R, Ni D, Wenting X, Upur H: Prevalence of BRCA1 and BRCA2 germline mutations in breast cancer Women of Multiple Ethnic Region in Northwest China. J Breast Canc 2013, 16: 50\u201354. 10.4048\/jbc.2013.16.1.50","journal-title":"J Breast Canc"},{"key":"146_CR7","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Canc Re 2007, 13: 4429\u20134434. 10.1158\/1078-0432.CCR-06-3045","journal-title":"Clin Canc Re"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS: Triple-negative breast cancer. N Engl J Med 2010, 363: 1938\u20131948. 10.1056\/NEJMra1001389","journal-title":"N Engl J Med"},{"key":"146_CR9","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 2008, 26: 4282\u20134288. 10.1200\/JCO.2008.16.6231","journal-title":"J Clin Oncol"},{"key":"146_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10549-012-2001-0","volume":"133","author":"BH Son","year":"2012","unstructured":"Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH, KOHBRA Research Group and Korean Breast Cancer Society: Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Breast Canc Res Treat 2012, 133: 1143\u20131152. 10.1007\/s10549-012-2001-0","journal-title":"Breast Canc Res Treat"},{"key":"146_CR11","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr2118","volume":"10","author":"E Thirthagiri","year":"2008","unstructured":"Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH: Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Canc Res 2008, 10: R59. 10.1186\/bcr2118","journal-title":"Breast Canc Res"},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00432-006-0105-9","volume":"132","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, Shao ZM: Te prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Canc Res Clin Oncol 2006, 132: 617\u2013626. 10.1007\/s00432-006-0105-9","journal-title":"J Canc Res Clin Oncol"},{"key":"146_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jmedgenet-2011-100006","volume":"48","author":"DG Evans","year":"2011","unstructured":"Evans DG, Howell A, Ward D, Lalloo F, Jones JL, Eccles DM: Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet 2011, 48: 520\u2013522. 10.1136\/jmedgenet-2011-100006","journal-title":"J Med Genet"},{"key":"146_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-011-1433-2","volume":"129","author":"E Comen","year":"2011","unstructured":"Comen E, Davids M, Kirchhoff T, Hudis C, Offit K, Robson M: Relative contributions of BRCA1 and BRCA2 mutations to\u2018triple-negative\u2019breast cancer in Ashkenazi Women. Breast Canc Res Treat 2011, 129: 185\u2013190. 10.1007\/s10549-011-1433-2","journal-title":"Breast Canc Res Treat"},{"key":"146_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","volume":"17","author":"AM Gonzalez-Angulo","year":"2011","unstructured":"Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, Lanchbury JS, Stemke-Hale K, Hennessy BT, Arun BK, Hortobagyi GN, Do KA, Mills GB, Meric-Bernstam F: Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Canc Res 2011, 17: 1082\u20131089. 10.1158\/1078-0432.CCR-10-2560","journal-title":"Clin Canc Res"},{"key":"146_CR16","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-03-1061","volume":"10","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, B\u00e9gin LR, Narod SA: Estrogen receptor status in BRCA1 and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Canc Res 2004, 10: 2029\u20132034. 10.1158\/1078-0432.CCR-03-1061","journal-title":"Clin Canc Res"},{"key":"146_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-008-0096-0","volume":"115","author":"WJ Yin","year":"2009","unstructured":"Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM: Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Canc Res Treat 2009, 115: 325\u2013333. 10.1007\/s10549-008-0096-0","journal-title":"Breast Canc Res Treat"},{"key":"146_CR18","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/bcr3347","volume":"14","author":"SY Phuah","year":"2012","unstructured":"Phuah SY, Looi LM, Hassan N, Rhodes A, Dean S, Mohd Taib NA, Yip CH, Teo SH: Triple negative breast cancer and phosphatase and tensin homolog loss are predictors of BRCA1 germline mutations in women with early onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Breast Canc Res 2012, 14: R142. 10.1186\/bcr3347","journal-title":"Breast Canc Res"},{"key":"146_CR19","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1200\/JCO.2010.28.0719","volume":"28","author":"JS Kwon","year":"2010","unstructured":"Kwon JS, Gutierrez-Barrera AM, Young D, Sun CC, Daniels MS, Lu KH, Arun B: Expanding the criteria for BRCA mutation testing in Breast cancer survivors. J Clin Oncol 2010, 28: 4214\u20134220. 10.1200\/JCO.2010.28.0719","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-19-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:31:30Z","timestamp":1630557090000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/2047-783X-19-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1186\/2047-783x-19-35","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]},"assertion":[{"value":"21 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}